Canagliflozin, a sodium-glucose cotransporter-2 (SGLT2) inhibitor, attenuates pancreatic fibrosis in chronic pancreatitis through the AMPK-OPG-CTGF axis.
- DOI
- 10.1016/j.pan.2026.05.006
- Published
- 2026 Aug
- Container
- Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.pan.2026.05.006,
title = {Canagliflozin, a sodium-glucose cotransporter-2 (SGLT2) inhibitor, attenuates pancreatic fibrosis in chronic pancreatitis through the AMPK-OPG-CTGF axis.},
author = {Adachi A and Kato H and Kato A and Yoshida M and Hori Y and Toyohara T and Oda K and Kito Y and Urakabe K and Mori T and Takahashi S and Kataoka H},
year = {2026},
journal = {Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]},
doi = {10.1016/j.pan.2026.05.006},
url = {https://doi.org/10.1016/j.pan.2026.05.006}
}RIS
TY - JOUR TI - Canagliflozin, a sodium-glucose cotransporter-2 (SGLT2) inhibitor, attenuates pancreatic fibrosis in chronic pancreatitis through the AMPK-OPG-CTGF axis. AU - Adachi A AU - Kato H AU - Kato A AU - Yoshida M AU - Hori Y AU - Toyohara T AU - Oda K AU - Kito Y AU - Urakabe K AU - Mori T AU - Takahashi S AU - Kataoka H PY - 2026 JO - Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] DO - 10.1016/j.pan.2026.05.006 UR - https://doi.org/10.1016/j.pan.2026.05.006 ER -
APA
A, A., H, K., A, K., M, Y., Y, H., T, T., K, O., Y, K., K, U., T, M., S, T., & H, K. (2026). Canagliflozin, a sodium-glucose cotransporter-2 (SGLT2) inhibitor, attenuates pancreatic fibrosis in chronic pancreatitis through the AMPK-OPG-CTGF axis.. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]. https://doi.org/10.1016/j.pan.2026.05.006
Source records
- pubmed · retrieved 2026-09-26T15:13:52.641Z
- europe-pmc · retrieved 2026-09-26T15:13:52.637Z